FMR1 and autism: Pre-delivery treatments with Oxt or with a selective NKCC1 inhibitor in a model of autism, the valproate rat, and in a model of fragile X, the Fmr1−/− mouse, were shown to rescue the altered GABA balance in pups and social behavioral deficits in adults (Tyzio et al., 2014).